Antisense inhibition of gene expression during Xenopus development was obtained by injecting, into the zygote, an expression vector carrying the adenovirus VAI gene read by RNA polymerase III. This vector yields high levels of antisense RNA in most embryonic cells between mid-blastula transition and tailbud stage. As a target we chose the Xenopus homeobox gene XhoxlA. A 26 bp long oligonucleotide, including the initiation codon of this gene, was inserted in opposite polarity into the vector. Antisense treatment reduces XhoxlA mRNA in embryos up to stage 22 and XhoxlA protein expression up to stage 30. Half of the antisense-treated embryos develop a characteristic phenotype with disorganized somites in the anterior trunk and delayed development of the intestinal tract.
Introduction
The antisense RNA approach, developed in Xenopus oocytes (Melton, 1985; Weintraub et al., 1985) , has mainly been applied to the study of gene function in cultured cells (for reviews see Walder, 1988; Colman, 1990) . However, its attractive application to inhibiting gene expression during embryogenesis has encountered difficulties. Antisense molecules have to be present in large excess (Melton, 1985) but, in the Xenopus embryo, both antisense RNA (Bass and. Weintraub, 1987; Rebagliati and Melton, 1987) and synthetic oligonucleotides (Cazenave et al., 1987; Shuttleworth and Colman, 1988; Woolf et al., 1990) are rapidly degraded. Even chemically modified molecules have a short half-life but may intercept maternal mRNAs in Xenopus blastomeres (Shuttleworth and Colman, 1988; Dagle et al., 1990; Torpey et al., 1992) . Direct injection of antisense molecules produced in vitro seems inapt to inhibit embryonic target mRNAs at later stages of development (Cho et al., 1988; Wright et al., 1989) . Moreover, injection of oligode-* Corresponding author, Tel.: +41 22 3499925; Fax: +41 22 3492647. oxynucleotides into Xenopus oocytes can disturb translation of various mRNAs (Woolf et al., 1992) and create a variety of aberrations in cell metabolism and structure (Smith et al., 1990 ).
An alternative approach, successfully used in cultured cells and consisting of producing antisense RNA in situ from an expression vector, has only rarely been applied to embryos. One group has reported partial inhibition of protein 4.1 using an antisense expression vector under the control of the mouse sarcoma virus LTR (Giebelhaus et al., 1988) but, in general, promoters read by RNA polymerase II yield low levels of RNA, and no inhibition was obtained by others using a similar approach (for review see Vize et al., 1991) . An improved vector has been developed (Schmid et al., 1992) that is also transcribed by RNA polymerase II (thymidine kinase promoter) but contains in addition a bovine papilloma viral DNA segment that grants replication of the injected construct up to the tadpole stage. Although the antisense effect has not been assessed on the target a-actin mRNA or protein level, antisense inhibition with this vector caused some abnormalities in somite formation.
We developed an expression vector containing the VAI gene of adenovirus type 2 (Akusjkvi et al., 1980) Development 52 (I 995) 3749 transcribed by RNA polymerase III and yields high levels of RNA in the host embryos up to developmental stage 30. Antisense RNA is transcribed from a short target gene segment inserted in the opposite direction into the VAZ gene.
Initial experiments aiming at inhibiting the expression of the abundantly expressed cytokeratin l/8 gene (for gene and its normal expression, cf. Franz and Franke, 1986; Fouquet et al., 1988) gave only partial (40%) reduction of the target mRNA between developmental stages 15 and 20 and did not reduce target protein levels (own unpublished results). Nevertheless, the results encouraged us to attempt the inhibition of the homeobox gene XhoxlA which has a much lower level of expression (Harvey et al., 1986; Dekker et al., 1992) .
Homeobox genes are attractive targets for inhibition assays, because they play an important role in embryonic localization (for review see Krumlauf, 1994) . Several such genes have also been cloned from Xenopus and their normal expression pattern has been mapped. However, functional tests of their role in embryonic development have been limited until now to overexpressing mRNA from injected, in vitro transcribed mRNA (Harvey and Melton, 1988 ; Ruiz i Altaba and , or intercepting the protein product by injected antibodies (Cho et al., 1988) . The homeobox gene XhoxlA used here as an antisense target is expressed early in development, mainly in the postcranial mesoderm (Harvey et al., 1986; Dekker et al., 1992) . We show that antisense RNA produced from an expression vector read by RNA polymerase III abolishes or strongly diminishes target mRNA levels in treated embryos up to developmental stage 22, and impairs the expression of XhoxlA protein up to stage 30. Treated embryos develop a characteristic phenotype exhibiting heavy disorganization in tissues in which the target gene is normally expressed. The main defect caused by the antisense treatment resides in the development of postcranial somites and resembles the disturbances caused by overexpression of XhoxlA mRNA (Harvey and Melton, 1988) .
Materials and methods

In vitro fertilization and injection of Xenopus zygotes
Injection of DNA into zygotes resembles the technique used by Rusconi and Schaffner (1979) . Xenopus laevis wild type (African Xenopus facility, Noordhoek RSA) or aP albino females (Xenopus center, Geneva) were injected with human chorionic gonadotropin (Pregnyl; N.V. Organon) to induce ovulation. Eggs were stripped from the female and fertilized in vitro (Thiebaud et al., 1984) with finely chopped testis fragments in Marc's modified amphibian Ringer solution (see Peng, 1991) , diluted with 2 ~01s. of water at use. After 10 min, aged water was added for 5 min and then the fertilized eggs were rapidly (6 min) dejellied in 3% cysteine (pH 7.8), washed extensively in aged water, and transferred to OR2 solution (Wallace et al., 1973) with antibiotics (50 IU penicillin and 50 pglml streptomycin, 20 ,ug/ml kanamycin). Injection (as described for oocytes, cf. Bertrand et al., 1991) of 200 pg of DNA in 10 nl of nuclear injection buffer (88 mM NaCl, 1 mM KCl, 15 mM Hepes, pH 7) into the center of the zygote was performed 15-60 min after washing. Perfectly cleaving 4-cell embryos were selected. The OR2 solution was then gradually diluted and the embryos cultured at 22°C in aged water with antibiotics. Embryonic stages were determined according to Nieuwkoop and Faber (1956) .
Gene clones and probes for SI analysis
The VAIS, plasmid consists of pEMBL 9 (Dente et al., 1983 ) with a Bali fragment of 600 bp containing the VA1 gene (bases 10210-10810 of adenovirus type 2; Akusjarvi et al., 1980) inserted into its SmaI site. To remove the BamHI site of the pEMBL9 polylinker, this clone was cut with HincII (which also eliminates some non-transcribed VA1 adjacent sequences) and the large fragment was religated to give plasmid VA1 .
To construct plasmid VlA-, and VlA+, pVA1 was opened at the internal BamHI site and a 26 bp oligonucleotide corresponding to a XhoxlA mRNA segment from 1 nucleotide before to 20 bases behind the first ATG (for sequences, cf. Harvey et al., 1986 ) plus a BamHI site (5 bases) in 5' position and a BamHI compatible sticky end on the other strand. Orientation was determined by recutting with BamHI the recognition site for which was reconstituted only on one side of the insert, and either Hind111 or EcoRI located up-or downstream of the VA1 gene. Similarly, VlAL-was produced by inserting a 38 bp oligonucleotide containing 35 bp corresponding to nucleotides -18 to +17 relative to the adenosine of the ATG of the XhoxlA mRNA. Three base substitutions had to be introduced (G for A at -10, -6, and -2) to eliminate T4 stretches in antisense orientation. To construct pASK-, VA1 was cut with BamHI (blunted) and EcoRI excising the 3' part of the VAZ gene, and a 130 bp NcoI (blunted)/ EcoRI fragment (bases l-120 covering the first AUG plus 10 bp of pEMBL) from pKXL1/8 (Franz and Franke, 1986) was inserted in antisense orientation.
Transcripts from these clones were analyzed by Si protection assays using a kinased 470 bp probe fragment isolated from VAIS, by cutting with BamHI. This 5' segment is common to all VAI derived clones and normally initiated transcripts yield a protected fragment of 71 bases.
The following gene clones were used for in vitro transcription of riboprobes for RNase protection assays. TO construct pBSClA a 1030 bp BamHI fragment of 64TClA containing cXhox-IA (Harvey et al., 1986) was subcloned into the BamHI site of PBS(+) (Stratagene). A 350 bp EcoRVPstI fragment from this clone was inserted into PBS(+) to yield pBSClAS', used to produce the XhoxlA-specific riboprobe after linearizing with EcoRI. EF-laPst1 is a bluescript KS+ (Stratagene) construct with a 794 bp EcoRI/PstI insert of EF-la (Krieg et al., 1989) and was linearized with NcoI for in vitro transcription. All work with bacteria, DNA and RNA, unless indicated differently, was carried out according to Sambrook et al. (1989) .
Analysis of RNAs
RNA was isolated from batches of 10 healthy embryos through a procedure involving digestion with proteinase K (1 mg/ml), several extractions with phenol<hloroform, chloroform-isoamyl alcohol, and precipitated with 4 M LiCl. Aliquots of 20 ,ug of the total RNA pellet, measured by OD, were used for S1 protection assays (Dierks et al., 1983) .
Probable secondary structure of VA1 transcripts was determined using the Zuker algorithm from PC/Gene (A. Bairoch, University of Geneva, IntelliGenetics
Inc. Release 6.80/December 1993). RNase protection assays were done on DNasedigested, total RNA according to standard procedures (Sambrook et al., 1989) . For quantitative evaluation, gels were scanned (Ofoto 1 .O.l, Light sources, computer images, Inc), and analyzed by Mac Image (1 SO, NIH).
In situ hybridization
Whole-mount in situ hybridization was done according to Hemmati-Brivanlou et al. (1990) as modified by Harland (1991) . VAI-specific RNA probes containing digoxigenin were synthesized with T7 polymerase from an XbaI-linearized PBS (Stratagene) clone containing the XbaI/EcoRI fragment of the VA1 plasmid. Whole-mount preparations were photographed on a Wild photomacroscope M400. To visualize staining of internal structures, the dorsal mesoderm and ectoderm were manually isolated from some whole-mount preparations.
Histological paraffin sections (5 pm) were prepared for in situ hybridization (Doll6 and was expressed in bacteria and their acetone powder was used for removing antibodies reacting with the XhoxlA homeobox and possibly also with homeoboxes of other genes. For work with antibodies, we used standard procedures (Harlow and Lane, 1988) .
The preabsorbed immunoglobulin fraction (0.1 mg/ml) was used in dilution 1:20 for whole-mount staining (Dent et al., 1989) of albino embryos. To compare intensity of staining, embryos from the same batch were stained simultaneously, and photographic processing was done under identical conditions.
For histological examination, embryos were fixed according to Smith (Peng, 1991) and longitudinal, 6-pm paraffin sections stained by the trichromic Masson technique (Humason, 1972) . Photographs were taken on a Zeiss Axiophot using Nomarski interference optics.
Results
Expression of a vector transcribed by polymerase III in Xenopus embryos
In preparative experiments, we characterized the behavior of DNA injected in circular or linear form into the zygote. Our results closely resemble those published by others (for review see Vize et al., 1991) . Briefly, circular DNA seems not to be replicated, but declines only slowly to disappear around stage 30. Linear vectors have a tendency to ligate even incompatible ends and to circularize in mono-or dimers. Only few copies of high molecular weight DNA, possibly included in genomic DNA, are seen at later stages of development.
However, the amounts of RNA produced from circular vectors are higher than those produced from originally linear vectors. We also determined the amounts of DNA to be injected, using 25, 75, 200, 500 and 1000 pg per zygote, respectively. The results showed that 200 pg is the highest amount that does not markedly affect survival of the host embryos. All further experiments were thus carried out injecting 200 pg of circular DNA.
We then tested various promoters read by RNA polymerase II, the early genes of SV40 and polyoma virus, and the inducible human major heat shock (hsp70) promoter (Voellmy et al., 1985) . The constitutive viral genes are switched on at mid-blastula transition but yield very low levels of RNA between stages 10 and 18. The inducible hsp70 promoter can be heat-activated after midblastula transition and produces a somewhat higher level of RNA which, however, declines rapidly. High mortality in DNA injected and heat-treated embryos renders a re- peated induction of the heat shock vector problematic. The level of RNA produced by any of the polymerase II vectors tested was too low to attempt antisense inhibition. Genes read by RNA polymerase III display an extremely high transcriptional activity in the Xenopus oocyte (Mazabraud et al., 1987) . For practical reasons, namely the need of inserting antisense segments, we chose the VAI gene from adenovirus type 2 (Akusjkvi et al., 1980) that has a handy BamHI site just behind the B promoter block. Transcripts from the VAZ gene injected into the Xenapus zygote are first detected around midblastula transition and immediately reach a maximum at stage 10 to slowly decrease and become undetectable by stages 30-35 depending on the batch of embryos (Fig. I) . The level of antisense transcripts is as high as that of VA1 RNA at stages 10-12. However, once target mRNA is formed, the level of antisense RNA is consistently reduced compared to VA1 transcripts (not shown), probably because the RNA hybrids are degraded. Northern blot analyses carried out on CK8, CK.55 mRNAs (Fouquet et al., 1988 ) and on EFla mRNA (Krieg et al., 1989) with the same RNA confirmed equal amounts and integrity of the RNA samples (not shown).
Distribution and expression of the VA1 vector in various regions of the embryo was monitored by in situ hybridization. In whole-mount preparations of stage 15 embryos, strong labeling by a VAI-specific probe is found almost over the entire embryo with only a few unlabeled sectors ( Fig. 2A-C ). The endoderm generally shows weaker reaction (Fig. 2C) . Uninjected embryos as well as embryos carrying the pEMBL8 vector without VAZ gene, are not labeled (Fig. 2D) . In situ hybridization on histological sections using a radioactive VA1 probe (Fig. 2E) shows that virtually all ectodermal and mesodermal cells are labeled although to slightly variable degrees. The endoderm exhibits a much weaker staining. Two features may explain this weak staining; endodermal cells, at least in the mouse embryo, transcribe polymerase III genes with a low efficiency (White et al., 1989) and, digoxigenin reaction is known to work poorly in the endoderm. At later stages (18, 22) staining still extends over the entire embryo. This is shown on manually dissected wholemount preparations of dorsal mesodermal fragments of stage 22 embryos carrying the VA1 vector (Fig. 3A,B) with even staining of the mesodermal tissues, whereas embryos carrying the control pEMBL vector are not stained (Fig. 3C) . Expression of the VA1 vector thus seems to be sufficiently ubiquitous to allow meaningful antisense inhibition.
Stability of VA1 transcripts with and without antisense inserts
The VA1 gene was chosen, because it has a BamHI site behind the intragenic A and B promoter blocks (Fig. 4A) . Insertion behind the promoter does not affect efficiency of transcription (Galli et al., 1981) but may alter stability of the RNA (Mellits and Mathews, 1988) . We determined the most probable secondary structure (Zuker algorithm) assumed by the RNA transcribed from VAI, VIA-with a 26 bp antisense insert, and ASK-in which the 3' half of the VAZ gene was replaced by 130 bp of inverted cytokeratin g-coding sequences with a T3 cluster 76 bp downstream of the insertion point. The resulting RNA structures are shown in Fig. 4B . The predicted structure of the VA1 RNA corresponds to that published (Mellits and Mathews, 1988) . According to such a model, the XhoxlA antisense insert in VIA-RNA forms no stable double-stranded structure and, by this criterion, may be free to interact with a complementary mRNA. The ASK-RNA assumes a configuration with unpaired ends.
The RNA levels produced in stage 10 embryos from these vectors are shown in Fig. 4C . Stable double stranded stems seem to be a prerequisite for stability of the RNA in the embryo. Both VA1 and VlA-RNAs that have a stable stem structure according to theoretical data, are also recovered in high amounts. The presence of the antisense insert does not reduce RNA stability. By contrast the level of ASK-RNA that, by its sequence, cannot form a stable stem structure, is by far lower. Transcription of ASK-in the oocyte is as efficient as that of VA1 and VIA-(not shown) and the low level of ASK-RNA must thus be due to its low stability in the embryo. At stage 10, no XhoxlA mRNA (Dekker et al., 1992) and very little maternal cytokeratin 8 mRNA are present (Fouquet et al., 1988) , and no interference through degradation of eventual hybrids has to be expected. Based on this analysis, we used antisense constructs with short inserts in all further experiments, in the present study thus the VlA-vector. As a control, the VA1 vector was used, because the VIA+ construct has a T, cluster in its XhoxlA insert and yields truncated transcripts and low RNA levels.
Effect of antisense inhibition on XhoxlA mRNA levels
To verify, whether inhibition by antisense RNA acts through degradation of the target mRNA (Nellen and Lichtenstein, 1993) , or through any of the other possible mechanisms (maturation, transport, ribosome attachment, inosine substitution; cf. Walder, 1988; Kimelman and Kirschner, 1989; Colman, 1990) , we measured the level of XhoxlA mRNA in uninjected controls and in embryos injected with either the VA1 or the VIA-antisense vector. Fig. 5A shows an RNase protection assay carried out with RNA isolated from three embryos each at stages 18, 22, or 25 of development. Xhoxl A mRNA yields four main protected bands probably due to the presence of A ciusters in the region hybridizing with the probe, leading to thermolabile, RNase-sensitive blobs. The four bands protected by XhoxlA mRNA were scanned together and the level of EFla mRNA in the same sample was used as internal standard. At stage 18, VAl-antisense-treated embryos contained only 17% of XhoxlA target mRNA present in uninjected controls (100%). Note that the VA1 controls also had a reduced XhoxlA mRNA level (56%), possibly due to a slight developmental delay. XhoxlA--treated embryos had only 3% of mRNA compared to untreated controls (lOO%), whereas the VA1 controls were now higher (123%). By stage 25, XhoxlA mRNA was not reduced any longer by antisense treatment compared to VAI controls (74 and 78%, respectively; controls 100%). Variations by 25% seem to be due to imprecision of this measurement (see also 123% above, and 125% below). Taken together, the amount of antisense RNA produced is sufficient to reduce the expression of the XhoxlA target gene only to about early tailbud stage.
To assess variability of antisense inhibition, we analyzed RNA from single embryos at stage 21 (Fig. 4B) . Individual embryos carrying the VIA-antisense vector have 10, 15, 125, 52, and 35%, respectively, of XhoxlA mRNA compared to a control (100%) carrying the VA1 vector, taking into account the variation in RNA recovery measured by the internal EFla standard.
Reduction in XhoxlA mRNA was also visualized by whole-mount in situ hybridization using a probe specific for XhoxlA mRNA. Embryos carrying the VA1 control vector are indistinguishable from uninjected controls (Fig.  6A.B) . By contrast, in 11 out of 19 embryos carrying the VIA-antisense vector XhoxlA staining was virtually extinct (Fig. 6C) . Another four embryos were weakly stained and four were unaffected.
In Xenupus, the plane of the first cleavage corresponds to the future medial plane of the embryo (see e.g. Harvey and Melton, 1988) . Thus, the VlA-vector was injected into one blastomere of the two-cell stage. Among such embryos, 6 out of 9 showed unilateral in situ staining for XhoxlA mRNA (Fig. 6D) .
Effect of antisense treatment on the protein level
Degradation of Xhox 1 A mRNA described above ought to be reflected on the XhoxlA protein level. Antibodies directed against a XhoxlA fusion protein were used for whole-mount staining of albino embryos that were injected with either VAI contiol, or VlA-antisense vector. Staining is very faint until about stage 25 of development and extinction of XhoxlA protein at earlier stages could thus not be ascertained. The localization of Xhoxl A expression in a stage 25 control embryo is shown in Fig.  7A . Emigrating neural crest cells and the dorsal mesoderm of the anterior trunk are stained in a gradient-like fashion decreasing in caudal direction. The neural tube shows no staining (cf. dorsal view in Fig. 7E ). The lateral plates are very faintly stained in the same region. The antibody also stains the somites in a segmental pattern. Upon antisense treatment, staining is strongly reduced in about half of the embryos analyzed (Fig. 7B) .
At stage 30, staining for XhoxlA in controls (Fig. 7C ) is localized as a dorsal cone in the neck region, corresponding to migrating neural crest cells and dorsal and lateral mesoderm. The striped staining in the myotomes decreases in caudal direction. In some of the antisensetreated embryos, Xhox 1 A expression was still reduced at this stage and the striped pattern in the somites was consistently disturbed (Fig. 7D) . Injection of the antisense vector into one blastomere at the two-cell stage yields embryos exhibiting a marked reduction in XhoxlA expression in one body half (Fig. 7E) .
Effect of antisense treatment on the phenotype
The observation of a given larval phenotype in Xenopus is rendered difficult by the spontaneous occurrence of abnormal development that may considerably vary in frequency between batches of embryos. DNA injection into the zygote tends to further augment the incidence of non-specific malformations.
We carried out 12 independent injection series comparing the overall effect of injection of the VA1 and VlAvectors. To eliminate malformations due to the injection manipulation per se, we selected stage 13 embryos that had undergone normal gastrulation. From this stage on, Survival rate did not change in embryos carrying the VlA-antisense vector. As many as 72% (398/550) reached stage 35. However, malformations were much more frequent and amounted to 54% (2151398).
A particular phenotype occurs, in a more or less pronounced form but at high frequency, in antisense-treated embryos. Compared to a VAI-injected, normal stage 35 tadpole (Fig. 8A) , a XhoxlAphenotype (Fig. 8B ,C) shows poor segmentation and reduced size of the somites in the anterior trunk, often leading to a bent body axis. The intestinal tract is poorly developed resulting in a 'hollow' belly. At stage 42, the disturbance in the somites is even more pronounced and the delay in intestinal differentiation is obvious (antisense-treated embryo Fig. 8E ; control Fig. SD ). Strong phenotypes are not able to recover and usually die, whereas milder phenotypes do recover and undergo metamorphosis normally.
The frequency of the XhoxlA-phenotype was scored in another seven injection series (Table 1) . Again, normal gastrulae were selected and the phenotype of the developing larvae was assessed at stage 35 before loss of heavy phenotypes occurs. The results show that, among the VA1 injected embryos, incidence of the XhoxlA-phenotype is low except for series 4 where, possibly for genetic reasons, 23% of the larvae spontaneously developed such disturbances.
Nonetheless, both the overall frequency (8%) and the mean percentage (5%) are markedly lower in the VA1 controls than in the antisense-treated embryos (42% and 47%, respectively).
To test the specificity of antisense treatment, additional experiments were carried out with a VlAL-vector that carries a 35 bp long antisense insert. For technical reasons, three bases were substituted (G for A) to eliminate T4 stretches. This vector also gave XhoxlA-phenotypes but their frequency was lower (33%, n = 65) than with the perfectly matching shorter antisense probe VlA-(see above).
Tissue alterations foAllowing antisense inhibition
Stage 42 embryos derived from zygotes injected with VA1 control, or VlA-antisense vector were processed for histological examination. Antisense-treated embryos show prominent alterations in their intestinal tract and somites of the anterior trunk, whereas no marked changes were observed in the central nervous system. Fig. 9 illustrates malformations in the intestinal tract of a mild phenotype. Whereas intestinal epithelia and liver of a VA1 control larva are well differentiated (Fig. 9A) , the intestine of an antisense-treated larva is poorly differentiated and constituting cells still contain yolk granules (Fig. 9B) . Among mesenchymal derivatives, the blood island contains very few erythrocytes (Fig 9D) , compared to a normal counterpart (Fig. 9C) .
The most striking alterations in tissue organization following antisense treatment are found in the somites. The skeletal muscle of a VA1 control (stage 42) consists of densely packed muscle fibers arranged into clearly delimited segments (Fig. lOA) . By contrast, arrangement of muscle fibers in the anterior trunk region of antisensetreated larvae is heavily disturbed, even in a mild XhoxlA-phenotype (Fig. IOB-D) . Muscle segments are poorly delimited. Muscle fibers show reduced density, are loosely aligned, may run individually, cross each other, or form star-like aggregates. Close to the notochord, we observed muscle fibers with a perturbed sarcomeric organization due to enlarged A bands (Fig. IOE) . By contrast, the organization of somites in the posterior trunk is less affected and is entirely normal in the tail region.
Discussion
Technical aspects
The VA1 expression vector fulfills most requirements needed to grant reliable inhibition of endogenous gene expression in the Xenopus embryo. Producing antisense RNA in situ during development avoids some problems linked to toxic effects (Smith et al., 1990 ), short half-life (Cazenave et al., 1987; Shuttleworth and Colman, 1988; Woolf et al., 1990) and unequal distribution (Harvey and Melton, 1988 ) encountered with injected oligodeoxynucleotides or in vitro transcribed RNA. As shown, a DNA vector is rather evenly distributed and expressed in most embryonic cells. The vector, read by RNA polymerase III, yields RNA levels that are lO-lOO-fold higher than those produced by any of the polymerase II vectors tested. A similar VA1 vector has been developed independently and was found to inhibit SV40 early gene expression in COSl cells (Jennings and Molloy, 1987) . From the experience collected in the present study and from some recent methodological developments, several points should be considered when designing an antisense vector for Xenopus embryos. It has been found (see e.g. Torpey et al., 1992; Nellen and Lichtenstein, 1993) that it is not possible to predict from the secondary mRNA structure those regions that are best accessible for complementary antisense molecules. RNase H protection assays with synthetic oligonucleotides and in vitro transcribed target mRNA allow us to determine which antisense molecule hybridizes best in the presence of proteins. Recent findings indicate, however, that the location of the target sequence is less important than the length and concentration of the antisense segment, 15 bases being sufficient to grant efficient inhibition (Fakler et al., 1994) . We have shown here that, in the Xenopus embryo, targeted mRNA is degraded, in which case also antisense molecules complementary to 3' sequences are functional (Kim and Wold, 1985) . It is possible, however, that inhibition of ribosome attachment also contributes to the antisense effect (Melton, 1985) and, unless T clusters are present in this region, an antisense RNA covering the translation initiation site may be preferred.
The antisense coding segment should be introduced into the BamHI site of the VAZ gene, behind the A and B promoter blocks in order not to abolish promoter efficiency (Galli et al., 198 1; Mellits and Mathews, 1988) . No >T3 cluster should occur in the antisense insert be- Sarcomeric striation is missing in some cells (S). Necrotic nuclei can be observed (N). (E) Sarcomeric striation of muscle fibers shows altered periodicity (arrows) with enlarged A bands. Bars, 50pm. cause, depending on the sequence environment, po-20, and the amount of protein was not affected (own, unlymerase III might stop at this signal (Galli et al., 1981) .
published results). The less abundant XhoxlA mRNA, as Transcription should proceed to the end of the VAI gene, shown here, was strongly reduced at stage 18 and 22, and as a stable stem loop structure seems to be a prerequisite expression of the target protein was impaired up to stage for the stability of the transcripts.
30 of development. The present approach has its limitations. No antisense RNA is produced before mid-blastula transition. Elimination of maternal mRNA has thus to be attempted through injection of in vitro synthesized antisense molecules. The duration of inhibition is also limited. After stage 22, the amount of antisense RNA becomes too low to grant inhibition. This limit evidently depends on the abundance of target mRNA. The highly abundant cytokeratin l/8 mRNA could only be reduced by about 40% up to stage
The observed reduction of target mRNA indicates that at least part of the antisense effect is due to RNA degradation. A mechanism involving RNase III activity on RNA-RNA hybrids is well established for prokaryotes, and preliminary indications existed for similar enzymes to act in eukaryotes (Nellen and Lichtenstein, 1993) . The present data and other observations (Strickland et al., 1988; Wulf et al., 1993) describing reduction of target RNA in the presence of antisense RNA constitute evi-A. Nichols et al. I Mechanisms ofDevelopment 52 (1995) 37-49 47 dence for an RNA/RNA degradation mechanism in eukaryotes. Apparently, RNA degradation occurs before 'unwindase activity' (Bass and Weintraub, 1987; Rebagliati and Melton, 1987) would dissociate the duplexes formed between the antisense RNA and the target mRNA. Anyhow, unwinding would be accompanied by substitution of adenosines by inosines (Kimelman and Kirschner, 1989 ) and lead to abortive translation.
Specificity of antisense inhibition is reflected in the different effects caused by different antisense vectors. The VIA-vector coding for a perfectly matching 21 bases long antisense insert, yields a higher frequency of XhoxlA-phenotypes than the VlAL-construct coding for a 35 bases long antisense segment that contains three mismatches (introduced to avoid T'IT stretches) and that can form perfect hybrids only over 18 bases. Moreover, we never obtained an accumulation of XhoxlA-phenotypes among embryos carrying an antisense vector directed against cytokeratin 8 mRNA (not shown). Finally, similar experiments carried out using a VAX6-vector carrying a 30 bp long oligonucleotide corresponding to the first 30 coding bases of the Xlhbox 6 gene (Wright et al., 1990 ) gave 11% of tail axis defects (n = 106) whereas the sense control, VAX6+, or non-injected embryos showed only 3% and 2%, respectively, of such a phenotype (Chappuis, Nichols and Rungger, unpublished results). The Xlhbox6-phenotype with a disturbed tail axis again reflects the localization of the target gene and is clearly different from the Xhox 1 A-phenotype.
Whereas specificity seems granted, a major problem resides in the observation that reduction in target mRNA as well as target protein, or appearance of a specific phenotype varies among individual embryos. We have observed temporary inhibition (up to stage 22) of target mRNA in more than half of the embryos tested, but to a variable degree. At later stages (stage 25), when the target protein becomes detectable, still about half of the embryos show a reduction in its level, or a disturbance in its expression pattern. It is known that a large excess of antisense molecules is needed to obtain full inhibition of a target gene, and this excess may be difficult to reach in the embryo. Reduced antisense levels in some of the cells, eventually due to imperfect distribution or variable expression of the vector, may then lead to a situation where the operational limit is not reached. In addition, antisense effect on the target mRNA level is limited to early stages of development, and the bulk of target protein synthesis takes place after this stage. Nevertheless, this temporary and partial inhibition, does cause disturbances in the expression pattern of the protein and, lateron, typical alterations in an appreciable proportion of the individuals treated. Such partial penetrance implies, however, that evaluation of antisense effects has to rely on the analysis of numerous embryos.
Homologous recombination (Capecchi, 1989) would be a safer means to suppress a gene product. However, the persistence of free circles (or circularized linear DNA) in Xenopus blastomeres excludes both positive selection for cells with integrates and negative selection against random integrates. Knockout experiments are thus not easy to adapt to this species.
Biological effects of XhoxlA inhibition
The homeobox gene XhoxlA (Harvey et al., 1986) shows extensive sequence homology with the gene deformed of Drosophila melanogaster and gene Hox2.6 of the mouse (Graham et al., 1988; Dekker et al., 1992) , newly named Hox4B (Krumlauf, 1994) . In vertebrates, homeobox genes of the Antennapedia family are duplicated in four paralogues . In addition, Xenopus laevis is a pseudotetraploid species (Kobel and DuPasquier, 1986 ) and thus, eight paralogues might exist. Indeed, two versions of the XhoxlA gene exist in X. laevis (Fritz and DeRobertis, 1989) . We ignore whether corresponding members of different paralogues have identical function and whether the antisense RNA intercepts their mRNA with equal efficiency.
XhoxlA transcription starts at stage 10.5, reaches a peak level by stage 15 and then gradually diminishes up to stage 30 (Dekker, et al., 1992) . Transcripts accumulate in the postcranial somitic mesoderm, lateral plates, and neural tube (Harvey et al., 1986) . Localization of XhoxlA protein (cf. Figs. 45) in the emigrating neural crest, dorsal mesoderm, somites, and lateral plates of the anterior trunk coincides with this distribution of mRNA except for the neural tube, where we observed no staining for XhoxlA protein.
The main defect caused by antisense treatment against XhoxlA occurs in tissues in which the target gene is normally expressed. Muscle differentiation is strongly disorganized in antisense-treated embryos resulting in loose lateral co-alignment of muscle fibers, star-like arrangements, crossings, and even abnormal striation. Such alterations do not simply reflect a delay in differentiation. Normal somites of earlier stages do not exhibit such features. Moreover, the defects are limited to the anterior trunk region, become gradually weaker in the posterior trunk, and tail muscle in the same larvae is normally organized.
The observed disturbances in the arrangement of the muscle fibers (Fig. 10) resemble the disorders caused in Xenopus embryos by overexpression of injected XhoxlA mRNA which also resulted in local star-like arrangement of muscle fibers and, in extreme cases, in a loss of segmentation (Harvey and Melton, 1988) . Apparently, overor underexpression of a gene product involved in embryonic determination and differentiation may cause similar effects. This was also observed when the product of another homeobox gene, XlHbox 1, was reduced by injected antibodies, or increased by overexpression of mRNA. Both treatments resulted in alterations of the anterior neural tube, forming a spina bifida . The mechanism by which XhoxlA interferes with somite differentiation is not established, but might involve regulation of cell adhesion molecule (CAM) expression. Two N-CAM genes are expressed in Xenopus embryos and in adult muscle (Tonissen and Krieg, 1993) . Interestingly, N-CAM expression is modulated by several homeobox proteins, Hox.2.5, -2. 4 and -3.3 (Jones et al., 1992, 1993) . A control of N-CAM expression by XhoxlA might thus be envisaged and explain why reduction (present results) or overexpression of XhoxlA (Harvey and Melton, 1988) and N-CAM (Kintner, 1988 ) result in similar phenotypes.
